Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies
Cartier Cuts 7.9 g/t Au Over 4.0 m Within A Broader Segment of 2.3 g/t Au Over 19.0 m at Hope Sector ; Unlocks New High-Grade Gold Zone in Underexplored Pontiac Sediments
CHARBONE annonce la signature d'un contrat d'approvisionnement de trois ans en oxygene UHP avec un client strategique americain, renforcant sa presence aux Etats-Unis
CHARBONE Announces the Signing of a Three-year UHP Oxygen Supply Contract with a Strategic American Customer, Strengthening its Presence in the United States